Bond Teva Pharma Finance NL III B.V. 8.125% ( US88167AAR23 ) in USD
| Issuer | Teva Pharma Finance NL III B.V. |
| Market price | |
| Country | Israel
|
| ISIN code |
US88167AAR23 ( in USD )
|
| Interest rate | 8.125% per year ( payment 2 times a year) |
| Maturity | 14/09/2031 |
|
Prospectus brochure in PDF format is unavailable at this time We will provide it as soon as possible |
|
| Minimal amount | 200 000 USD |
| Total amount | 500 000 000 USD |
| Cusip | 88167AAR2 |
| Standard & Poor's ( S&P ) rating | BB ( Non-investment grade speculative ) |
| Moody's rating | Ba1 ( Non-investment grade speculative ) |
| Next Coupon | 15/03/2026 ( In 91 days ) |
| Detailed description |
Teva Pharmaceutical Finance Netherlands III B.V. is a subsidiary of Teva Pharmaceutical Industries Ltd., a global pharmaceutical company, and functions as a financing vehicle within its broader corporate structure. The Bond issued by Teva Pharma Finance NL III B.V. ( Israel ) , in USD, with the ISIN code US88167AAR23, pays a coupon of 8.125% per year. The coupons are paid 2 times per year and the Bond maturity is 14/09/2031 The Bond issued by Teva Pharma Finance NL III B.V. ( Israel ) , in USD, with the ISIN code US88167AAR23, was rated Ba1 ( Non-investment grade speculative ) by Moody's credit rating agency. The Bond issued by Teva Pharma Finance NL III B.V. ( Israel ) , in USD, with the ISIN code US88167AAR23, was rated BB ( Non-investment grade speculative ) by Standard & Poor's ( S&P ) credit rating agency. |
Français
Italiano
Israel